NEW YORK, NY – May 29, 2019 – The iRemedy Healthcare Companies announced the addition of the Nyloxin line of pain relief products to their marketplace today. Nyloxin was designed to be powerful without utilizing any opioid or narcotic ingredients.
The active ingredient in Nyloxin is cobra venom, which works as a potent pain relief agent by introducing specialized proteins to block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off. In some clinical studies, Nyloxin pain relieving products could provide prolonged chronic muscle and joint relief.
“Providing people alternatives to narcotics-based pain relief medication is necessary for good communal health. That’s why we love this product and we’re glad to have it part of the iRemedy family.” said Tony Paquin, CEO of iRemedy.
Although cultures in Asia have been using cobra venom for millennia, its usefulness wasn’t recorded in the body of western pharmacology until the 19th century. The first purified neurotoxin from the cobra was introduced to market as an analgesic by Kunming Institute of Zoology in 1978.
About iRemedy Healthcare Companies, Inc.
iRemedy is a privately-held healthcare technology and product distribution company that works with industry leaders, including Medline, McKesson, large hospitals, medical practices and GPOs, to bring data-driven intelligence to the U.S. medical supply chain. The iRemedy platform is a ‘smart’ ecommerce solution based on the proprietary iRemedy SKU Data Platform that includes product distribution services. This platform combines transaction, billing, medical record and other data to create a more intelligent product SKU. iRemedy’s solutions combine the power of ecommerce and full supply chain fulfillment services with AI and EHR-integrated capabilities to bring diversity of suppliers, price transparency, predictive analysis and just-in-time inventory solutions that more precisely meet the needs of healthcare providers, large and small. For more information, please visit www.iremedy.com.
Director of Marketing
407-395-4283 | [email protected]